OSR Holdings, Inc. operates as a blank check company, also known as a special purpose acquisition company (SPAC), focused on identifying and acquiring a target business in the healthcare sector. The company's primary objective is to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. OSR Holdings aims to leverage its financial resources and strategic expertise to facilitate growth and operational improvements for the target company, ultimately creating...
| S.No. | Ticker | Company | Market Cap | P/E | P/S | Total Debt (Qtr) |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Inc / Ma | 110.07 Bn | 27.83 | 9.17 | - |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 78.64 Bn | 17.42 | 5.48 | 1.99 Bn |
| 3 | ALNY | Alnylam Pharmaceuticals, Inc. | 40.01 Bn | 145.45 | 12.70 | - |
| 4 | RVMD | Revolution Medicines, Inc. | 25.72 Bn | -22.78 | 30,991.05 | - |
| 5 | ZLAB | Zai Lab Ltd | 24.95 Bn | -142.38 | 102.91 | 0.20 Bn |
| 6 | MESO | Mesoblast Ltd | 23.40 Bn | -183.33 | 1,360.75 | 0.12 Bn |
| 7 | RPRX | Royalty Pharma plc | 21.22 Bn | 27.59 | 8.92 | 8.95 Bn |
| 8 | MRNA | Moderna, Inc. | 19.77 Bn | -6.99 | 10.17 | 0.59 Bn |